Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

COVID-19 Self-testing IMPROVE

  • Read more about COVID-19 Self-testing IMPROVE

Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

  • Read more about Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

Expanded Access Program for RP in Adults

  • Read more about Expanded Access Program for RP in Adults

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

  • Read more about A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

Assessment of Fit of Novel N95 Style Transparent Face Masks

  • Read more about Assessment of Fit of Novel N95 Style Transparent Face Masks

Evaluation of the Effectiveness of a Spa Treatment for People With Post-Covid 19 Conditions.

  • Read more about Evaluation of the Effectiveness of a Spa Treatment for People With Post-Covid 19 Conditions.

The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

  • Read more about The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

  • Read more about INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Comparison of ESP Block and M-TAPA Block Efficiency in Postoperative Analgesia Management in Nephrectomy Cases

  • Read more about Comparison of ESP Block and M-TAPA Block Efficiency in Postoperative Analgesia Management in Nephrectomy Cases

Kiromic BioPharma, Inc.

By jpalfreyman on Wed, 08/21/2024 - 16:22
  • Read more about Kiromic BioPharma, Inc.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Current page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA